Bradford T Whitmore - Net Worth and Insider Trading

Bradford T Whitmore Net Worth

The estimated net worth of Bradford T Whitmore is at least $155 Million dollars as of 2024-12-04. Bradford T Whitmore is the 10% Owner of Nanophase Technologies Corp and owns about 34,884,596 shares of Nanophase Technologies Corp (NANX) stock worth over $99 Million. Bradford T Whitmore is the Director, 10% Owner of Ultralife Corp and owns about 6,201,013 shares of Ultralife Corp (ULBI) stock worth over $48 Million. Bradford T Whitmore is also the 10% Owner of Clearside Biomedical Inc and owns about 6,845,186 shares of Clearside Biomedical Inc (CLSD) stock worth over $7 Million. Details can be seen in Bradford T Whitmore's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bradford T Whitmore has not made any transactions after 2024-02-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Bradford T Whitmore

To

Bradford T Whitmore Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bradford T Whitmore owns 3 companies in total, including Nanophase Technologies Corp (NANX) , Clearside Biomedical Inc (CLSD) , and Ultralife Corp (ULBI) .

Click here to see the complete history of Bradford T Whitmore’s form 4 insider trades.

Insider Ownership Summary of Bradford T Whitmore

Ticker Comapny Transaction Date Type of Owner
NANX Nanophase Technologies Corp 2024-02-08 10 percent owner
CLSD Clearside Biomedical Inc 2024-02-07 10 percent owner
ULBI Ultralife Corp 2023-12-08 10 percent owner

Bradford T Whitmore Latest Holdings Summary

Bradford T Whitmore currently owns a total of 3 stocks. Among these stocks, Bradford T Whitmore owns 34,884,596 shares of Nanophase Technologies Corp (NANX) as of February 8, 2024, with a value of $99 Million and a weighting of 64.04%. Bradford T Whitmore owns 6,201,013 shares of Ultralife Corp (ULBI) as of December 8, 2023, with a value of $48 Million and a weighting of 31.18%. Bradford T Whitmore also owns 6,845,186 shares of Clearside Biomedical Inc (CLSD) as of February 7, 2024, with a value of $7 Million and a weighting of 4.78%.

Latest Holdings of Bradford T Whitmore

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NANX Nanophase Technologies Corp 2024-02-08 34,884,596 2.84 99,072,253
ULBI Ultralife Corp 2023-12-08 6,201,013 7.78 48,243,881
CLSD Clearside Biomedical Inc 2024-02-07 6,845,186 1.08 7,392,801

Holding Weightings of Bradford T Whitmore


Bradford T Whitmore Form 4 Trading Tracker

According to the SEC Form 4 filings, Bradford T Whitmore has made a total of 10 transactions in Nanophase Technologies Corp (NANX) over the past 5 years, including 9 buys and 1 sells. The most-recent trade in Nanophase Technologies Corp is the acquisition of 3,824,864 shares on February 8, 2024, which cost Bradford T Whitmore around $2 Million.

According to the SEC Form 4 filings, Bradford T Whitmore has made a total of 21 transactions in Ultralife Corp (ULBI) over the past 5 years, including 21 buys and 0 sells. The most-recent trade in Ultralife Corp is the acquisition of 15,877 shares on December 8, 2023, which cost Bradford T Whitmore around $110,980.

According to the SEC Form 4 filings, Bradford T Whitmore has made a total of 10 transactions in Clearside Biomedical Inc (CLSD) over the past 5 years, including 9 buys and 1 sells. The most-recent trade in Clearside Biomedical Inc is the acquisition of 444,444 shares on February 7, 2024, which cost Bradford T Whitmore around $599,999.

Insider Trading History of Bradford T Whitmore

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bradford T Whitmore Trading Performance

GuruFocus tracks the stock performance after each of Bradford T Whitmore's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bradford T Whitmore is 4.9%. GuruFocus also compares Bradford T Whitmore's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bradford T Whitmore within 3 months outperforms 41 times out of 100 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bradford T Whitmore's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bradford T Whitmore

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
45 out of 97 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.47 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.21 LIMIT LIMIT LIMIT LIMIT LIMIT

Bradford T Whitmore Ownership Network

Ownership Network List of Bradford T Whitmore

No Data

Ownership Network Relation of Bradford T Whitmore

Insider Network Chart

Bradford T Whitmore Owned Company Details

What does Nanophase Technologies Corp do?

Who are the key executives at Nanophase Technologies Corp?

Bradford T Whitmore is the 10 percent owner of Nanophase Technologies Corp. Other key executives at Nanophase Technologies Corp include VP & Sales & Marketing & BD Kevin Cureton , Chief Financial Officer Jess Jankowski , and 10 percent owner Strandler, Llc .

Nanophase Technologies Corp (NANX) Insider Trades Summary

Over the past 18 months, Bradford T Whitmore made 2 insider transaction in Nanophase Technologies Corp (NANX) with a net purchase of 3,910,711. Other recent insider transactions involving Nanophase Technologies Corp (NANX) include a net purchase of 224,544 shares made by R Janet Whitmore , a net sale of 22,550 shares made by Jess Jankowski , and a net purchase of 16,391 shares made by Kevin Cureton .

In summary, during the past 3 months, insiders sold 0 shares of Nanophase Technologies Corp (NANX) in total and bought 106,637 shares, with a net purchase of 106,637 shares. During the past 18 months, 22,550 shares of Nanophase Technologies Corp (NANX) were sold and 4,151,646 shares were bought by its insiders, resulting in a net purchase of 4,129,096 shares.

Nanophase Technologies Corp (NANX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nanophase Technologies Corp Insider Transactions

No Available Data

Bradford T Whitmore Mailing Address

Above is the net worth, insider trading, and ownership report for Bradford T Whitmore. You might contact Bradford T Whitmore via mailing address: 5215 Old Orchard Road, Suite 620, Skokie Il 60077.

Discussions on Bradford T Whitmore

No discussions yet.